Predictions
Mercadolibre Inc
Start price
Target price
Perf. (%)
€990.90
12.09.22
12.09.22
€1,010.0
12.09.23
12.09.23
-8.14%
20.09.22
20.09.22
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Very low/no dividend yield expected
Columbia Care Inc.
Start price
Target price
Perf. (%)
€1.84
12.09.22
12.09.22
€1.10
12.09.23
12.09.23
-13.67%
13.10.22
13.10.22
Capable Management
Innovative
Bad rating
Few uniques
InMed Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€16.34
12.09.22
12.09.22
-
12.09.23
12.09.23
-93.70%
02.04.23
02.04.23
Could be very worthwhile Investment >20% year
Annovis Bio Inc.
Start price
Target price
Perf. (%)
€21.30
12.09.22
12.09.22
-
12.09.23
12.09.23
-31.92%
02.04.23
02.04.23
Could be worthwhile Investment >10% per year
Velodyne Lidar Inc.
Start price
Target price
Perf. (%)
€1.25
12.09.22
12.09.22
€1.00
12.09.23
12.09.23
-3.80%
13.09.22
13.09.22
Top 10 in its market
Innovative
Some uniques
Revenue decline/stagnation expected
Navya S.a.
Start price
Target price
Perf. (%)
€0.26
12.09.22
12.09.22
€0.80
12.09.23
12.09.23
-48.15%
12.12.22
12.12.22
Could be worthwhile Investment >10% per year
Catana Group
Start price
Target price
Perf. (%)
€6.24
10.09.22
10.09.22
-
10.09.23
10.09.23
9.29%
11.09.23
11.09.23
Could be worthwhile Investment >10% per year
T-Mobile US Inc.
Start price
Target price
Perf. (%)
€146.00
10.09.22
10.09.22
-
10.09.23
10.09.23
4.25%
29.10.22
29.10.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Valuable balance sheet
ROE higher than 10% per year
Procter & Gamble Co.
Start price
Target price
Perf. (%)
€139.20
10.09.22
10.09.22
€145.00
10.09.23
10.09.23
1.29%
30.11.22
30.11.22
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Good rating
ShiftPixy Inc.
Start price
Target price
Perf. (%)
€31.30
10.09.22
10.09.22
€4.00
10.09.23
10.09.23
-37.16%
17.09.22
17.09.22
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
Very low/no dividend yield expected
very negative Cash Flow expected
ShiftPixy Inc.
Start price
Target price
Perf. (%)
€31.30
10.09.22
10.09.22
€11.00
10.09.23
10.09.23
-37.16%
17.09.22
17.09.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
TCR2 Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.38
09.09.22
09.09.22
-
09.09.23
09.09.23
-6.96%
18.09.22
18.09.22
Risky Investment
Nacon S.a.
Start price
Target price
Perf. (%)
€4.72
09.09.22
09.09.22
-
09.09.23
09.09.23
-66.41%
10.09.23
10.09.23
Could be worthwhile Investment >10% per year
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€11.50
09.09.22
09.09.22
-
09.09.23
09.09.23
266.96%
18.05.23
18.05.23
Risky Investment
Geovax Labs Inc.
Start price
Target price
Perf. (%)
€1.39
09.09.22
09.09.22
-
09.09.23
09.09.23
-56.79%
18.05.23
18.05.23
Could be worthwhile Investment >10% per year
Koninklijke Ahold Delhaize NV
Start price
Target price
Perf. (%)
€27.86
09.09.22
09.09.22
€35.00
09.09.23
09.09.23
9.58%
30.05.23
30.05.23
VERBIO Vereinigte BioEnergie AG
Start price
Target price
Perf. (%)
€68.85
09.09.22
09.09.22
€85.00
09.09.23
09.09.23
-11.55%
17.09.22
17.09.22